Ligand validation:6QGX

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 6QGX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6QGX_C8E_A_1009	16%	88%	0.24	0.908	0.25	0.42	-	-	0	0	48%	0.4762
6QGX_C8E_A_1006	6%	86%	0.217	0.757	0.29	0.42	-	-	0	0	33%	0.3333
6QGX_C8E_A_1001	5%	87%	0.249	0.782	0.27	0.43	-	-	0	0	33%	0.3333
6QGX_C8E_A_1002	5%	88%	0.257	0.724	0.33	0.33	-	-	0	0	62%	0.619
6QGX_C8E_A_1011	4%	85%	0.274	0.761	0.26	0.48	-	-	0	0	48%	0.4762
6QGX_C8E_A_1003	0%	85%	0.613	0.633	0.26	0.47	-	-	0	0	33%	0.3333
6QGX_C8E_A_1007	0%	86%	0.541	0.562	0.27	0.45	-	-	0	0	33%	0.3333
6QGX_C8E_A_1004	0%	87%	0.478	0.433	0.29	0.41	-	-	2	0	48%	0.4762
6QGX_C8E_A_1005	0%	85%	0.616	0.433	0.26	0.48	-	-	0	0	48%	0.4762
6QGX_C8E_A_1008	0%	86%	0.894	0.262	0.28	0.43	-	-	0	0	48%	0.4762
6QGX_C8E_A_1010	0%	85%	0.684	0.019	0.26	0.47	-	-	0	0	48%	0.4762
6QGW_C8E_A_905	31%	85%	0.106	0.891	0.29	0.44	-	-	0	0	33%	0.3333
7NRF_C8E_A_1002	20%	69%	0.225	0.875	0.34	0.83	-	-	0	0	71%	0.7143
6QGY_C8E_A_905	15%	78%	0.228	0.845	0.41	0.46	-	-	0	0	67%	0.6667
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	2	0	100%	1
6EHD_C8E_A_409	64%	60%	0.105	0.903	0.41	1.08	-	2	3	0	100%	1
5MDO_C8E_B_404	61%	73%	0.118	0.908	0.36	0.65	-	-	0	0	100%	1
5DL7_C8E_A_506	61%	47%	0.123	0.912	0.72	1.34	-	3	4	0	100%	1
6HCP_C8E_C_824	59%	77%	0.116	0.924	0.46	0.46	-	-	1	0	86%	0.8571

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.